Jext

Epinephrine Bitartrate, the active ingredient in Jext, is a adrenergic agonist presented as a injection for intramuscular use. It treats acute anaphylactic reactions and other life‑threatening allergic emergencies in patients at risk of severe episodes.

GNH USA supplies Jext as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jext (epinephrine) is employed in the emergency management of severe allergic and related life‑threatening conditions.

Anaphylaxis: rapid reversal of airway obstruction, hypotension and mediator release. Severe asthma exacerbation: bronchodilation to relieve bronchospasm. Cardiac arrest (asystole/ventricular fibrillation): improves coronary and cerebral perfusion.

Common Side Effects: - Tremor - Palpitations - Anxiety

Serious or Rare Side Effects: - Severe hypertension - Cardiac arrhythmias - Myocardial ischemia

Jext should be used with caution in the following situations: - Assess for hypersensitivity: avoid use in patients with known allergy to epinephrine or its excipients. - Cardiovascular disease: use carefully in patients with coronary artery disease, hypertension, or arrhythmias. - Pregnancy: consider risk versus benefit; administer only if clearly needed. - Pediatric dosing: ensure weight‑based dosing and close monitoring. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive sympathomimetic effects. - β‑blockers: may blunt therapeutic response and increase severe hypertension risk.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect after epinephrine wears off. - Calcium channel blockers: may affect cardiovascular response. - Other sympathomimetics: additive cardiovascular stimulation.